-
公开(公告)号：EP4234026A2
公开(公告)日：2023-08-30
申请号：EP23181587.9
申请日：2020-03-12
申请人： OM Pharma SA
IPC分类号： A61P31/00
摘要： The present invention relates to novel stable bacterial extract preparations having substantial increased stability overtime, novel methods of preparation thereof, pharmaceutical formulations based on these novel stabilized bacterial extracts, as well as novel routes of administration and delivery devices for treating and/or preventing acute and chronic immunological disorders resulting from infections and/or inflammation and/or neoplasms and/or dysbiosis.
-
公开(公告)号：EP4234026A3
公开(公告)日：2024-07-03
申请号：EP23181587.9
申请日：2020-03-12
申请人： OM Pharma SA
IPC分类号： A61K35/74 , A61K9/08 , A61K39/02 , A61M15/08 , C12N1/06 , C12N1/08 , C12N1/20 , A61P37/00 , A61P31/00 , A61K39/39 , A61K47/02 , C12P1/04 , A61P11/00 , A61K9/00 , A61K39/00
CPC分类号： C12N1/06 , C12N1/08 , A61K35/74 , A61K9/0043 , A61K9/0078 , A61K9/08 , A61K47/02 , C12P1/04 , A61K39/39 , A61K2039/5559420130101 , Y02A50/30 , A61P37/00 , A61P11/00
摘要： The present invention relates to novel stable bacterial extract preparations having substantial increased stability overtime, novel methods of preparation thereof, pharmaceutical formulations based on these novel stabilized bacterial extracts, as well as novel routes of administration and delivery devices for treating and/or preventing acute and chronic immunological disorders resulting from infections and/or inflammation and/or neoplasms and/or dysbiosis.
-
-
搜索结果
3 条记录 (耗时 0.01 秒)
